We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Crawford and Company | NYSE:CRD.A | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.13 | -1.39% | 9.22 | 9.35 | 9.01 | 9.11 | 58,473 | 21:01:06 |
WATERLOO, ON, Dec. 5, 2015 /CNW/ - Crawford Class Action Services reports that the Supreme Court of British Columbia has required that notice of a certified class action against GlaxoSmithKline Inc. ("GlaxoSmithKline") be provided and has confirmed that an opt-in and opt-out deadline of April 4, 2016 applies for individuals wishing to participate. The class action was commenced in British Columbia in 2008 against GlaxoSmithKline as the manufacturer of the antidepressant called Paxil. The lawsuit alleged that ingestion of Paxil during pregnancy caused cardiovascular birth defects in newborns. The class action was certified on behalf of a National Class across Canada.
SOURCE Crawford & Company (Canada) Inc.
Copyright 2015 Canada NewsWire
1 Year Crawford Chart |
1 Month Crawford Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions